Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma.
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual.
Regenerative cellular therapies for neurologic diseases.
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.
Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.
Emerging oral agents for multiple sclerosis.
Multiple sclerosis: A lifestyle disease?
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.
Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Dimethyl fumarate (BG-12, Tecfidera) - NICE says yes in draft final guidance
Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1.
Biogen Idec reports death of patient on its MS pill
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
Current and future immunotherapy targets in autoimmune neurology.
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
DNA strand breakage by peroxidase-activated mitoxantrone.

Pages